A new technology has been developed and validated in an animal model and is currently in scientific validation using patients monitoring data. The invention consists in a method that allows high reliable quantification of the effect of respiration on the pulse pressure in patients with or without mechanical ventilation, even in situations in which the patient suffers from cardiac arrhythmias.
A first prototype system is under development by the scientific/clinician team.
Priority European patent application February 2018.
Additional data: CIC biomaGune transfer of technology office and CIBERES